Trial Profile

First-in-Human Phase I Trial of FL118 in Patients With Advanced Pancreatic Ductal Adenocarcinoma

Status: Withdrawn prior to enrolment

Phase of Trial: Phase I

Latest Information Update: 22 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs FL 118 (Primary)
Indications Adenocarcinoma; Pancreatic ductal carcinoma
Focus Adverse reactions; First in man; Pharmacokinetics

Most Recent Events

17 Jan 2025 Planned initiation date changed from 1 Oct 2024 to 1 Oct 2025.
17 Jan 2025 Status changed from not yet recruiting to withdrawn prior to enrolment. (never opened )
10 Apr 2024 Planned End Date changed from 15 May 2027 to 1 Oct 2027.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com